UPDATE 1-Anacor received rival bid before Pfizer deal - filing

May 26 (Reuters) - Anacor Pharmaceuticals Inc had

received an offer from a third party before it agreed to be

bought by Pfizer Inc in a $5.2 billion deal last week,

regulatory filings showed.

Read more